Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure

Congestive Heart Failure

Volumn 15, Issue 4, 2009, Pages 165-169

  Zareba, Karolina M ^a,b   Shenkman, Heather J ^c   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c California Cardiac Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITROGEN; UREA;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; SYSTOLIC HEART FAILURE; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; AGED; CHI-SQUARE DISTRIBUTION; DIASTOLE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE;

EID: 67651184164     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00097.x     Document Type: Article

References (20)

1. Konstam MA, Dracup K, Baker DW, et al. Heart failure: Evaluation and care of patients with left ventricular systolic dysfunction. J Card Fail. 1995;1:183-187.
2. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 1999;20:447-455.
3. Setaro JF, Soufer R, Remetz MS, et al. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol. 1992;69:1212-1216.
4. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurement of diastolic function. Circulation. 2002;105:1387-1393.
5. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
6. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768-777.
7. Kamath SA, Meo Neto Jde P, Canham RM, et al. Low voltage on the electrocardiogram is a marker of disease severity and a risk factor for adverse outcomes in patients with heart failure due to systolic dysfunction. Am Heart J. 2006;152:355-361.
8. Shenkman HJ, Pampati V, Khandelwal AK, et al. Congestive heart failure and QRS duration: Establishing prognosis study. Chest. 2002;122:528-534.
9. Perkiomaki JS, Zareba W, Greenberg HM, et al; Thrombogenic Factors and Recurrent Coronary Events Investigators. Usefulness of standard electrocardiographic parameters for predicting cardiac events after acute myocardial infarction during modern treatment era. Am J Cardiol. 2002;90:205-209.
10. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol. 2004;93:244-246.
11. de Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly: The Rotterdam Study. Circulation. 1998;97:467-472.
12. Piotrowicz K, Zareba W, McNitt S, et.al. Repolarization duration in patients with conduction disturbances after myocardial infarction. Am J Cardiol. 2007;99:163-168.
13. Okin PM, Malik M, Hnatkova K, et al. Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. J Cardiovasc Electrophysiol. 2005;16:945-951.
14. Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol. 2006;47:76-84.
15. Orea-Tejeda A, Colín-Ramírez E, Hernández-Gilsoul T, et al. Microalbuminuria in systolic and diastolic chronic heart failure patients. Cardiol J. 2008;15:143-149.
16. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.
17. Rautaharju PM, Prineas RJ, Wood J, et al. Electrocardiographic predictors of new-onset heart failure in men and in women free of coronary heart disease (from the Atherosclerosis in Communities [ARIC] Study). Am J Cardiol. 2007;100:1437-1441.
18. Breidthardt T, Christ M, Matti M, et al. QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart. 2007;93:1093-1097.
19. Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program. J Am Coll Cardiol. 2006;47:1997-2004.
20. Parkash R, Maisel W, Toca F, et al. Atrial fibrillation in heart failure: High mortality risk even if ventricular function is preserved. Am Heart J. 2005;150:701-706.